Results 351 to 360 of about 3,688,101 (379)
Some of the next articles are maybe not open access.
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends.
Journal of Medicinal Chemistry, 2016P. Zhan +3 more
semanticscholar +1 more source
Project Inform perspective, 2002
There continues to be progress in the development of a number of new anti-HIV drugs. Additional research has focused on optimizing the use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors (NNRTIs). This has resulted in studies of dual protease inhibitor combinations, protease inhibitor and NNRTI combinations and now dual NNRTI
openaire +1 more source
There continues to be progress in the development of a number of new anti-HIV drugs. Additional research has focused on optimizing the use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors (NNRTIs). This has resulted in studies of dual protease inhibitor combinations, protease inhibitor and NNRTI combinations and now dual NNRTI
openaire +1 more source
Project Inform perspective, 2002
Several studies of abacavir (Ziagen) were presented at the recent International Conference on AIDS in Durban. Most of the results are preliminary and are based only on interim analysis, but they do extend our knowledge of the use of the drug. They suggest that short-term use of a three-drug combination containing abacavir may be as effective as a three-
openaire +1 more source
Several studies of abacavir (Ziagen) were presented at the recent International Conference on AIDS in Durban. Most of the results are preliminary and are based only on interim analysis, but they do extend our knowledge of the use of the drug. They suggest that short-term use of a three-drug combination containing abacavir may be as effective as a three-
openaire +1 more source